indication

Amisulpride

Competitive landscape

as of 2026-07-01
Competitive set
1
0 approved · 1 pipeline

Projection timeline

actual past → guided future · protection walls overlaid
1 events
2024
2026
2028
2030
2032
2034
2036
2038
today
focal launch window
guided / estimated ↑
actual ↓
focal / guidedapprovallabel expansiontrial readoutcongressnclustered events (click to expand)guided (dashed = directional)competitor patent cliff

Competitive set

resolved drugs with trials in this indication
drugUnknown
Amisulpride
Pipeline · Early Phase 1
Early Phase 11 trial
OwnerShanghai Mental Health Center
Protection2038

Market size

prevalence as a range, not a number